Synthesis of programmable integrases

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 13, 2009, Pages 5053-5058

  Gordley, Russell M ^a   Gersbach, Charles A ^a   Barbas III, Carlos F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; DNA; INTEGRASE; RECOMBINASE; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER RECOMBINASE;

ACCURACY; ARTICLE; BIOTECHNOLOGY; CATALYSIS; CONTROLLED STUDY; DNA BINDING; DNA SEQUENCE; FLUORESCENCE; GENE THERAPY; GENOME; GENOTYPE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; TRANSGENE;

BINDING SITES; CATALYTIC DOMAIN; DNA-BINDING PROTEINS; GENE KNOCK-IN TECHNIQUES; GENE TARGETING; GENOME, HUMAN; HUMANS; INTEGRASES; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; RECOMBINASES; SUBSTRATE SPECIFICITY; TRANSGENES; ZINC FINGERS;

EID: 65249134039     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0812502106     Document Type: Article

References (43)

1. Sorrell DA, Kolb AF (2005) Targeted modification of mammalian genomes. Biotechnol Adv 23(7-8):431-469.
2. Thyagarajan B, Guimaraes MJ, Groth AC, Calos MP (2000) Mammalian genomes contain active recombinase recognition sites. Gene 244(1-2):47-54.
3. Schmidt EE, Taylor DS, Prigge JR, Barnett S, Capecchi MR (2000) Illegitimate Credependent chromosome rearrangements in transgenic mouse spermatids. Proc Natl Acad Sci USA 97:13702-13707.
4. Loonstra A, et al. (2001) Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci USA 98:9209-9214.
5. Liu J, Jeppesen I, Nielsen K, Jensen TG (2006) PhiC31 integrase induces chromosomal aberrations in primary human fibroblasts. Gene Therapy 13:1188-1190.
6. Chalberg TW, et al. (2006) Integration specificity of phage phiC31 integrase in the human genome. J Mol Biol 357:28-48.
7. Gordley RM, Smith JD, Graslund T, BarbasCF, III (2007) Evolution of programmable zinc finger-recombinases with activity in human cells. J Mol Biol 367:802-813.
8. Grindley ND, Whiteson KL, Rice PA (2006) Mechanisms of site-specific recombination. Ann Rev Biochem 75:567-605.
9. Klippel A, Cloppenborg K, Kahmann R (1988) Isolation and characterization of unusual gin mutants. EMBO J 7:3983-3989.
10. Arnold PH, Blake DG, Grindley ND, Boocock MR, Stark WM (1999) Mutants of Tn3 resolvase which do not require accessory binding sites for recombination activity. EMBO J 18:1407-1414.
11. Rozsa FW, Viollier P, Fussenegger M, Hiestand-Nauer R, Arber W (1995) Cin-mediated recombination at secondary crossover sites on the Escherichia coli chromosome. J Bacteriol 177:1159-1168.
12. Yang W, SteitzTA (1995) Crystal structure of the site-specific recombinase gamma delta resolvase complexed with a 34 bp cleavage site. Cell 82:193-207.
13. Chiu TK, Sohn C, Dickerson RE, Johnson RC (2002) Testing water-mediated DNA recognition by the Hin recombinase. EMBO J 21:801-814.
14. Segal DJ, Crotty JW, Bhakta MS, Barbas CF, III, Horton NC (2006) Structure of Aart, a designed six-finger zinc finger peptide, bound to DNA. J Mol Biol 363:405-421.
15. Pabo CO, Peisach E, Grant RA (2001) Design and selection of novel Cys2His2 zinc finger proteins. Ann Rev Biochem 70:313-340.
16. Maeder ML, et al. (2008) Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell 31:294-301.
17. Beerli RR & Barbas CF, III (2002) Engineering polydactyl zinc-finger transcription factors. Nat Biotechnol 20:135-141.
18. Beerli RR, DreierB, BarbasCF, III (2000) Positive and negative regulation of endogenous genes by designed transcription factors. Proc Natl Acad Sci USA 97:1495-1500.
19. Tan S, etal. (2003) Zinc-finger protein-targeted gene regulation: Genomewide singlegene specificity. Proc Natl Acad Sci USA 100:11997-12002.
20. Papworth M, et al. (2003) Inhibition of herpes simplex virus 1 gene expression by designer zinc-finger transcription factors. Proc Natl Acad Sci USA 100:1621-1626.
21. Eberhardy SR, et al. (2006) Inhibition of human immunodeficiency virus type 1 replication with artificial transcription factors targeting the highly conserved primerbinding site. J Virol 80:2873-2883.
22. Urnov FD, et al. (2005) Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435:646-651.
23. Perez EE, et al. (2008) Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 26:808-816.
24. Santiago Y, et al. (2008) Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proc Natl Acad Sci USA 105:5809-5814.
25. Akopian A, He J, Boocock MR, Stark WM (2003) Chimeric recombinases with designed DNA sequence recognition. Proc Natl Acad Sci USA 100:8688-8691.
26. Tan W, Dong Z, Wilkinson TA, Barbas CF, III, Chow SA (2006) Human immunodeficiency virus type 1 incorporated with fusion proteins consisting of integrase and the designed polydactyl zinc finger protein E2C can bias integration of viral DNA into a predetermined chromosomal region in human cells. J Virol 80:1939-1948.
27. Ivics Z, et al. (2007) Targeted Sleeping Beauty transposition in human cells. Mol Ther 15:1137-1144.
28. Nomura W, Barbas CF, III (2007) In vivo site-specific DNA methylation with a designed sequence-enabled DNA methylase. J Am Chem Soc 129:8676-8677.
29. Carroll D (2008) Progress and prospects: Zinc-finger nucleases as gene therapy agents. Gene Therapy 15:1463-1468.
30. FukushigeS, SauerB (1992) Genomic targeting with a positive-selection lox integration vector allows highly reproducible gene expression in mammalian cells. Proc Natl Acad Sci USA 89:7905-7909.
31. Thyagarajan B, Olivares EC, Hollis RP, Ginsburg DS, Calos MP (2001) Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol Cell Biol 21:3926-3934.
32. Hacein-Bey-Abina S, et al. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415-419.
33. CornuTI, etal. (2008) DNA-binding specificity is a major determinant of the activity and toxicity of zinc-finger nucleases. Mol Ther 16:352-358.
34. Smith AE, Hurd PJ, Bannister AJ, Kouzarides T, Ford KG (2008) Heritable gene repression through the action of a directed DNA methyltransferase at a chromosomal locus. J Biol Chem 283:9878-9885.
35. Hirata R, Chamberlain J, Dong R, Russell DW (2002) Targeted transgene insertion into human chromosomes by adeno-associated virus vectors. Nat Biotechnol 20:735-738.
36. WuSC, et al. (2006) piggyBacisa flexible and highly active transposonas compared to sleeping beauty, Tol2, and MosI in mammalian cells. Proc Natl Acad Sci USA 103:15008-15013.
37. Smithies O, Gregg RG, Boggs SS, Koralewski MA, Kucherlapati RS (1985) Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature 317:230-234.
38. Paques F, Duchateau P (2007) Meganucleases and DNA double-strand break-induced recombination: Perspectives for gene therapy. Curr Gene Therapy 7:49-66.
39. Roberts RJ (2005) How restriction enzymes became the workhorses of molecular biology. Proc Natl Acad Sci USA 102:5905-5908.
40. Dreier B, Beerli RR, Segal DJ, Flippin JD, Barbas CF, III (2001) Development of zinc finger domains for recognition of the 5'-ANN-3' family of DNA sequences and their use in the construction of artificial transcription factors. J Biol Chem 276:29466-29478.
41. Dreier B, et al. (2005) Development of zinc finger domains for recognition of the 5'-CNN-3' family DNA sequences and their use in the construction of artificial transcription factors. J Biol Chem 280:35588-35597.
42. Dreier B, Segal DJ, Barbas CF, III (2000) Insights into the molecular recognition of the 5'-GNN-3' family of DNA sequences by zinc finger domains. J Mol Biol 303:489-502.
43. Morgenstern JP, Land H (1990) Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18:3587-3596.